Skip to main content

Advertisement

SpringerLink
Log in

Critical care of intracerebral and subarachnoid hemorrhage

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

The acute management of primary intracerebral or aneurysmal subarachnoid hemorrhage requires a comprehensive approach involving stabilization of the patient, surgical intervention, and continued intensive care treatment of medical and neurologic complications. The are several causes of intracerebral hemorrhage (ICH), including hypertension, cerebral amyloid angiopathy, sympathomimetic drugs, and coagulopathies. More recently, use of thrombolytic agents in the treatment of acute ischemic stroke has increased the risk of ICH. Treatment of intracerebral hemorrhage is based on blood pressure control, and, in selected cases, surgical evacuation of clot. Patients with aneurysmal subarachnoid hemorrhage may experience rebleeding, symptomatic vasospasm, or hydrocephalus. Medical management in the intensive care unit with careful attention to fluid and electrolyte balance, nutrition, cardiopulmonary monitoring, and close observation for changes in the neurologic exam is vital. This review examines the diagnosis and intensive care management of patients with intracerebral or subarachnoid hemorrhage, and reviews some of the newer therapies for treatment of these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bamford J, Sandercock P, Dennis M, et al.: A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981–1986. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 1990, 53:16–22.

    PubMed  CAS  Google Scholar 

  2. Broderick JP: Natural history of primary intracerebral hemorrhage. In Population-Based Clinical Epidemiology of Stroke. Edited by Whisnant JP. Oxford: Butterworth-Heinemann; 1993:55–64.

    Google Scholar 

  3. Fogelholm R, Nuutila M, Vuorela AL: Primary intracerebral hemorrrhage in the Jyvaskyla region, Central Finland, 1985–1989: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry 1992, 55:546–552.

    PubMed  CAS  Google Scholar 

  4. Hijdra A, van Gijn J: Early death from rupture of an intracranial aneurysm. J Neurosurg 1982, 57:765–768.

    PubMed  CAS  Google Scholar 

  5. Ingall TJ, Wiebers DO: Natural history of subarachnoid hemorrhage. In Stroke: Populations, Cohorts, and Clinical Trials. Edited by Whisnant JP. Boston: Butterworth-Heinemann; 1993:174–186.

    Google Scholar 

  6. Albers GW, Amarenco P, Easton JD, et al.: Antithrombotic and thrombolytic therapy of ischemic stroke. Chest 2001, 119:300S-320S.

    Article  PubMed  CAS  Google Scholar 

  7. Ojemann RG, Heros RC: Spontaneous brain hemorrhage. Stroke 1983, 14:468–475.

    PubMed  CAS  Google Scholar 

  8. Calandre L, Arnal C, Fernandez Ortega J, et al.: Risk factors for spontaneous cerebral hematomas: case-control study. Stroke 1986, 17:1126–1128.

    PubMed  CAS  Google Scholar 

  9. Gorelick PB: The status of alcohol as a risk factor for stroke. Stroke 1989, 20:1607–1610.

    PubMed  CAS  Google Scholar 

  10. Fogelholm R, Eskola K, Kiminkinen T, et al.: Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1992, 55:1121–1124.

    PubMed  CAS  Google Scholar 

  11. Katzan IL, Furlan AJ, Lloyd LE, et al.: Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000, 283:1151–1158.

    Article  PubMed  CAS  Google Scholar 

  12. Alberts RG, Bates VE, Clark WM, et al.: Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000, 283:1145–1150.

    Article  Google Scholar 

  13. Suarez JI, Sunshine JL, Tarr R, et al.: Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30:2094–2100.

    PubMed  CAS  Google Scholar 

  14. Hart RG, Benavent O, Pearce LA: Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 1999, 9:215–217.

    Article  PubMed  CAS  Google Scholar 

  15. Rosand J, Hylek EM, O’Donnell HC, et al.: Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000, 55:947–951. These authors examined the role of cerebral amyloid angiopathy (CAA) in warfarin-associated intracerebral hemorrhage (ICH). Clinical characteristics and APOE genotype were compared between 41 patients with warfarin-related ICH and 66 randomly selected individuals without ICH taking warfarin; both groups were patients aged 65 years or more. Hemorrhages tended to be in the lobar regions of the brain, and most (76%) occurred with an international normalized ration of less than 3.0. The APOE ε2 allele was over-represented among patients with warfarin-associated lobar hemorrhage. CAA was pathologically diagnosed as the cause of lobar hemorrhage in seven of 11 patients with available tissue samples. In this study, CAA appeared to be an important cause of warfarinassociated lobar ICH in the elderly.

    PubMed  CAS  Google Scholar 

  16. Karnik R, Valentin A, Ammerer HP, et al.: Outcome in patients with intracerebral hemorrhage: predictors of survival. Wien Klin Wochenschr 2000, 112:169–173.

    PubMed  CAS  Google Scholar 

  17. Massaro AR, Sacco RL, Mohr JP, et al.: Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank. Neurology 1991, 41:1881–1885.

    PubMed  CAS  Google Scholar 

  18. Fuentes B, Diez-Tejedor E: The advantages of a stroke unit in the treatment of intracerebral hemorrhage. Rev Neurol 2000, 31:171–174.

    PubMed  CAS  Google Scholar 

  19. Martin NA, Saver J: Intensive care management of subarachnoid hemorrhage, ischemic stroke, and hemorrhagic stroke. Clin Neurosurg 1999, 45:101–112.

    PubMed  CAS  Google Scholar 

  20. Broderick JP, Brott T, Tomsick T, et al.: Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993, 78:188.

    PubMed  CAS  Google Scholar 

  21. Ropper AH, Gress D: Computerized tomography and clinical features of large cerebral hemorrhages. Cerebrovasc Dis 1991, 1:38–42.

    Google Scholar 

  22. Mayer SA, Lignelli A, Fink ME, et al.: Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 1998, 29:1791–1798.

    PubMed  CAS  Google Scholar 

  23. Poungvarin N, Bhoopat W, Viriyavejakul A, et al.: Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987, 316:1229–1233.

    Article  PubMed  CAS  Google Scholar 

  24. Yu YL, Kumana CR, Lauder IJ, et al.: Treatment of acute cerebral hemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomized trial. Stroke 1992, 23:967–971.

    PubMed  CAS  Google Scholar 

  25. Italian Acute Stroke Study Group: Haemodilution in acute stroke: results of the Italian Haemodilution trial. Lancet 1988, 1:318–320.

    Google Scholar 

  26. Juvela S, Heiskanen O, Poranen A, et al.: The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989, 70:755–758.

    PubMed  CAS  Google Scholar 

  27. Mohr JP, Caplan LR, Melski JW, et al.: The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978, 28:754–762.

    PubMed  CAS  Google Scholar 

  28. Fujii Y, Shigekazu T, Sasaki O, et al.: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998, 29:1160–1166.

    PubMed  CAS  Google Scholar 

  29. Dunne JW, Chakera T, Kermode S: Cerebellar haemorrhagediagnosis and treatment: a study of 75 consecutive cases. Q J Med 1987, 64:739–754.

    PubMed  CAS  Google Scholar 

  30. Zhu XL, Chan MSY, Poon WS: Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? Stroke 1997, 28:1406–1409.

    PubMed  CAS  Google Scholar 

  31. Gill JS, Shipley MJ, Tsementzis SA, et al.: Alcohol consumption: a risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med 1991, 90:489–497.

    PubMed  CAS  Google Scholar 

  32. Longstreth WT Jr, Nelson LM, Koepsell TD, et al.: Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke 1992, 23:1242–1249.

    PubMed  Google Scholar 

  33. Sacco RL, Elkind M, Boden-Albala B, et al.: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999, 281:53–60.

    Article  PubMed  CAS  Google Scholar 

  34. Clark WM, Albers GW, Madden KP, et al.: The rtPA (alteplase) 0 to 6-hour acute stroke trial, part A (Ao276g): result of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 2000, 31:811–816.

    PubMed  CAS  Google Scholar 

  35. Gebel JM, Brott TG, Sila CA, et al.: Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. Stroke 2000, 31:596–600. In this study, patients with spontaneous intracerbral hemorrhage (ICH) were compared with those with thrombolysis-related ICH in terms of the development of perihematomal edema, a factor that contributes to clinical deterioratation and death following ICH. All patients were imaged within 3 hours of clinical onset and relevant neuroimaging features were determined, including identification and quantification of perihematomal edema. There was striking qualitative and quantitative lack of perihematoma edema observed in the thrombolysis-related ICH compared with those that occurred spontaneously. The authors propose that intrahematomal blood clotting, as seen in spontaneous ICH, is a plausible pathogenetic factor in hyperacute perihematomal edema formation.

    PubMed  CAS  Google Scholar 

  36. Swanson RA: Intravenous heparin for acute stroke: what can we learn from the megatrails? Neurology 1999, 52:1746–1750.

    PubMed  CAS  Google Scholar 

  37. Gorter JW: Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention in Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999, 53:1319–1327.

    PubMed  CAS  Google Scholar 

  38. Chinese Acute Stroke Trial (CAST) Collaborative Group: CAST: a randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997, 349:1641–1649.

    Article  Google Scholar 

  39. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 1997, 349:1569–1581.

    Article  Google Scholar 

  40. McCabe DJ, Brown MM, Clifton A: Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke 1999, 30:2483–2486. A single case report of a 68-year-old normotensive man referred for evaluation of 95% stenosis of the left internal carotid artery (ICA). A left carotid percutaneous transluminal stenting was performed without any initial complications, but Doppler ultrasound of the ICA immediately after the stenting revealed an elevated peak systolic velocity of 230 cm/s. The patient deteriorated several hours after the procedure and computed tomography scan of the brain showed an extensive intracerebral hemorrhage. The patient died 18 days after the stenting. The authors suggest that intracerebral hemorrhage may occur as a hyperperfusion phenomenon after ICA stenting, but in the presence of only mild to moderate hypertension.

    PubMed  CAS  Google Scholar 

  41. Broderick JP, Adams HP, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905–915.

    PubMed  CAS  Google Scholar 

  42. Wijdicks EF, Schievink WO, Brown RD, et al.: Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 1999, 52:676–677.

    PubMed  CAS  Google Scholar 

  43. Brott TG, Broderick JP, Kothari R, et al.: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1–5.

    PubMed  CAS  Google Scholar 

  44. Juvela S, Heiskanen O, Poranen A, et al.: The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989, 70:755–758.

    PubMed  CAS  Google Scholar 

  45. McKissock W, Richardson A, Taylor J: Primary intracerebral hemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961, 2:221–226.

    Article  Google Scholar 

  46. Fernandes HM, Mendelow AD: Spontaneous intracerebral haemorrhage: a surgical dilemma. Br J Neurosurg 1999, 13:389–394.

    Article  PubMed  CAS  Google Scholar 

  47. Zuccarello M, Brott T, Derex L, et al.: Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999, 30:1833–1839. This small, randomized feasibility study attempted to examine early surgical evacuation of intracerebral hemorrhage (ICH) versus nonoperative management in patients with spontaneous supratentorial ICH. The primary endpoint was the 3-month Glasgow Outcome Scale (GOS). Twenty patients were randomized over 24 months: nine to surgical intervention and 11 to medical treatment. The median time from onset of symptoms to presentation at the treating hospitals was 3 hours and 17 minutes, and the time from onset of symptoms to surgery was 8 hours and 35 minutes. The likelihood of a good outcome for the surgical treatment group (56%) did not differ significantly from the medical treatment group (36%), but there was a trend toward less 3-month morbidity with surgical intervention. These results, according to the authors, warrant further investigation of very early clot removal in larger randomized clinical trials.

    PubMed  CAS  Google Scholar 

  48. Wijdicks EF, Atkinson JD: Clinician’s biases toward surgery in cerebellar hematomas: an analysis of decision-making in 94 patients. Cerebrovasc Dis 2000, 10:93–96.

    Article  PubMed  CAS  Google Scholar 

  49. Montes JM, Wong JH, Fayad PB, et al.: Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma: protocol and prelinimary experience. Stroke 2000, 31:834–840. The authors report preliminary experience with patients harboring intracerebral hemorrhage (ICH) treated by stereotactic computed tomographic (CT)-guided thrombolysis and aspiration of the clot. Twelve patients with supratentorial ICH without suspected underlying structural etiology or coagulopathy were treated. A catheter was directed stereotactically or manually into the ICH through a burr hole under CT guidance. Hematoma aspiration was followed by instillation of urokinase (5000 to 10,000 IU), which was repeated every 6 to 8 hours at bedside. The ICH volume reduction averaged 57%. At 6 months, 25% of patients had achieved good recovery, 42% of patients were dependent, and 8% were vegetative. Three patients (25%) died in the hospital from medical complications. The authors concluded that CT-guided thrombolysis and aspiration appeared safe and effective in reducing ICH volume.

    PubMed  CAS  Google Scholar 

  50. Weir B: Epidemiology. In Aneurysms Affecting the Nervous System. Edited by Weir B. Baltimore: Williams & Wilkins; 1987:19–53.

    Google Scholar 

  51. Schievink WI, Michels VV, Piepgras DG: Neurovascular manifestations of heritable connective tissue disorders: a review. Stroke 1994, 25:889–903.

    PubMed  CAS  Google Scholar 

  52. Kassell NF, Kongable GL, Torner JC, et al.: Delay in referral of patients with ruptured aneurysms to neurological attention. Stroke 1985, 16:587–590.

    PubMed  CAS  Google Scholar 

  53. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968, 28:14–20.

    PubMed  CAS  Google Scholar 

  54. Anderson GB, Steinke DE, Petruk KC, et al.: Computed tomographic angiography versus digital subtraction angiography for the diagnosis and early treatment of ruptured intracranial aneurysms. Neurosurgery 1999, 45:1315–1320.

    Article  PubMed  CAS  Google Scholar 

  55. Alexander MS, Dias PS, Uttley D: Spontaneous subarachnoid hemorrhage and negative cerebral panangiography. J Neurosurg 1986, 64:537–542.

    Article  PubMed  CAS  Google Scholar 

  56. Lownie SP, Pelz DM, Fox AJ: Endovascular therapy of a large vertebral artery aneurysm using stent and coils. Can J Neurol Sci 2000, 27:162–165. Endovascular treatment of a wide-necked aneurysm of the distal left vertebral artery was performed using a flexible coronary stent and platinum coils. A 5-mm diameter and 3-cm length coronary artery stent was placed across the base of the aneurysm, then seven Guglielmi detachable coils were deposited within the aneurysmal lumen. Although the postembolization angiogram showed incomplete occlusion, there were no further complications. The patient tolerated the procedure well and was maintained on 325 mg/d of aspirin. Suggested future modifications of this rapidly evolving technology include use of covered stents to occlude the wide-necked large aneurysms.

    PubMed  CAS  Google Scholar 

  57. Kassell NF, Torner JC, Haley EC Jr, et al.: The International Cooperative Study on the Timing of Aneurysm Surgery. 1. Overall management results. J Neurosurg 1990, 73:18–36.

    PubMed  CAS  Google Scholar 

  58. Kassell NF, Sasaki T, Colohan AR, et al.: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985, 16:562–572.

    PubMed  CAS  Google Scholar 

  59. Fisher CM, Kistler JP, Davis JM: Relationship of cerebral vasospasm to subarachnoid hemorrhage visualized by CT scanning. Neurosurgery 1980, 6:1–9.

    Article  PubMed  CAS  Google Scholar 

  60. Adams HP Jr, Kassell NF, Torner JC, et al.: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT result, and antifibrinolytic therapy: a report of the Cooperative Aneurysm Study. Neurology 1987, 37:1586–1591.

    PubMed  Google Scholar 

  61. Sloan MA, Burch CM, Wozniak MA, et al.: Transcranial Doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage. Stroke 1994, 25:2187–2197.

    PubMed  CAS  Google Scholar 

  62. Pickard JD, Murray GD, Illingworth R, et al.: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ 1989, 298:636–642.

    PubMed  CAS  Google Scholar 

  63. Bernardini GL, Mayer SA, Kossoff SB, et al.: Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms. Crit Care Med, 2001, 29:641–644.

    Article  PubMed  CAS  Google Scholar 

  64. Muizelarr JP, Zwienenberg M, Rudisill NA, et al.: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999, 91:51–58. The authors studied a group of 13 patients with Fisher Grade 3 (thick clot subarachnoid hemorrhage on admission computed tomography scan) who had a very high probability of developing vasospasm. In all patients, regardless of the site of ruptured aneurysm, potential target vessels for prophylactic transluminal balloon angioplasty (TBA) included internal carotid artery, A1 anterior cerebral artery and M1 middle cerebral artery segments, P1 posterior cerebral artery segment bilaterally, the basilar, and vertebral artery. TBA was considered satisfactory when it was performed in at least two of the three parts of the intracranial circulation, including the aneurysm-bearing part of the circulation. Of the 13 patients, none developed delayed ischemic neurologic deficits or more than mild vasospasm according to transcranial Doppler unltrasonography criteria (see Table 5). At 3-months post-treatment, eight patients had made a good recovery; one patient died because of a vessel rupture during TBA; two others died due to medical complications. The extremely low incidence of vasospasm and delayed neurologic deficits in these patients following prophylactic TBA certainly warrants a larger, randomized study to determine whether TBA is efficacious enough to justify the inherent risks.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurology and Neurosurgery, Albany Medical Center, 47 New Scotland Avenue, MC-70, 12208-3479, Albany, NY, USA

    Gary L. Bernardini MD, PhD & Eric M. DeShaies MD

Authors
  1. Gary L. Bernardini MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric M. DeShaies MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernardini, G.L., DeShaies, E.M. Critical care of intracerebral and subarachnoid hemorrhage. Curr Neurol Neurosci Rep 1, 568–576 (2001). https://doi.org/10.1007/s11910-001-0064-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-001-0064-0

Keywords

Search

Navigation